Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 41
Item hits:
Issue DateTitleAuthor(s)
1-Nov-2018Challenges and opportunities in the clinical development of immune checkpoint inhibitors for hepatocellular carcinomaFlynn, MJ; Sayed, AA; Sharma, R; Siddique, A; Pinato, DJ, et al
1-Jun-2018High test positivity and low positive predictive value for colorectal cancer of continued faecal occult blood test screening after negative colonoscopyBrown, JP; Wooldrage, K; Wright, S; Nickerson, C; Cross, AJ, et al
13-Mar-2018SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cellsNestal de Moraes, G; Ji, Z; Lavender, F; Yao, S; Zona, S, et al
1-Jun-2018The FOXO3-FOXM1 Axis: a key cancer drug target and a modulator of cancer drug resistanceYao, S; Fan, YN; Lam, EW; Biotechnology and Biological Sciences Research Council (BBSRC); Imperial College Trust, et al
8-Jun-2018Targeting autophagy sensitises lung cancer cells to Src family kinase inhibitorsPardo, OE; Rupniewska, E; Roy, R; Mauri, FA; Liu, X, et al
4-May-2018Extensive and systematic rewiring of histone post-translational modifications in cancer model systemsNoberini, R; Osti, D; Miccolo, C; Richichi, C; Lupia, M, et al
15-Mar-2018LMTK3 confers chemo-resistance in breast cancerStebbing, J; Shah, K; Lit, LC; Gagliano, T; Ditsiou, A, et al
13-Aug-2018Copy-number signatures and mutational processes in ovarian carcinomaMacintyre, G; Goranova, TE; De Silva, D; Ennis, D; Piskorz, AM, et al
1-Oct-2018Number of adenomas removed and colorectal cancers prevented in randomized trials of flexible sigmoidoscopy screeningPinsky, PF; Loberg, M; Senore, C; Wooldrage, K; Atkin, W, et al
1-Jul-2018Biomarker assessment of HR deficiency, tumor BRCA1/2 mutations and CCNE1 copy number in ovarian cancer: associations with clinical outcome following platinum monotherapyStronach, EA; Paul, J; Timms, KM; Hughes, E; Brown, K, et al